Altimmune(DE:3G0)
€1.550.00 (-10.42%)
DE:3G0
Altimmune earnings date
€1.55
At close:0.00 (-10.42%)
Altimmune (3G0) Q2 2023 Earnings Report
9 Followers
DE:3G0 Q2 2023 EPS Results
- Actual EPS
- -EUR 0.29
- Consensus EPS
- -EUR 0.42
- Beat/Miss
- Beat by +EUR 0.13
- One Year Ago EPS
- -EUR 0.38
DE:3G0 Q2 2023 Revenue Results
- Actual Revenue
- EUR 5,442.903
- Expected Revenue
- EUR 2,721.451
- Beat/Miss
- Beat by +EUR 2,721.451
- YoY Revenue Growth
- -25.00%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/10/2023
- Time
- Before Open
- Conference Call
- Thursday, August 10, 2023
DE:3G0 Upcoming Earnings
Altimmune's next earnings date is estimated for March 3, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
DE:3G0 Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:3G0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 03, 2027 | 2026 (Q4) | -0.15- | -0.24 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.12-0.14 | -0.19 | 28.57% (+0.05) | |
| Aug 12, 2026 | 2026 (Q2) | -0.13-0.11 | -0.24 | 55.56% (+0.14) | |
| May 13, 2026 | 2026 (Q1) | -0.22-0.16 | -0.24 | 30.77% (+0.07) | |
| Mar 05, 2026 | 2025 (Q4) | -0.22-0.24 | -0.3 | 18.18% (+0.05) | |
| Nov 06, 2025 | 2025 (Q3) | -0.25-0.19 | -0.29 | 34.38% (+0.10) | |
| Aug 12, 2025 | 2025 (Q2) | -0.30-0.24 | -0.32 | 22.86% (+0.07) | |
| May 13, 2025 | 2025 (Q1) | -0.32-0.24 | -0.31 | 23.53% (+0.07) | |
| Feb 27, 2025 | 2024 (Q4) | -0.30-0.30 | -0.49 | 38.89% (+0.19) | |
| Nov 12, 2024 | 2024 (Q3) | -0.32-0.29 | -0.35 | 17.95% (+0.06) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
